Literature DB >> 14661906

The changes of multifocal electroretinography in the early stage of photodynamic therapy for choroidal neovascularization.

Libin Jiang1, Chenjin Jin, Feng Wen, Shizhou Huang, Dezheng Wu, Lezheng Wu.   

Abstract

To investigate short-term changes in the multifocal electroretinography (ERG) recordings after photodynamic therapy (PDT) for choroidal neovascularization (CNV), 16 patients (17 eyes) with classic CNV confirmed by fluorescein angiography (FA) and indocyanine green angiography (ICGA), including 11 cases (12 eyes) of exudative age-related macular degeneration (AMD), two cases (two eyes) of pathological myopia and three cases (three eyes) of idiopathic causes, were treated using PDT with verteporfin. The multifocal ERGs of these patients were tested with VERIS Science 4.0 imaging system. The latencies and average response densities of all six ring retinal regions were measured and compared before PDT and 3 or 7 days after PDT. The latencies and amplitude densities of the N1 and P1 waves in all six rings remained unchanged at 3 or 7 days post-treatment (p > 0.05). Therefore, there is no significant evidence to suggest an adverse effect from PDT for classic CNV on the outer retinal function in the early stage of treatment, with the aid of the multifocal ERG recordings.

Entities:  

Mesh:

Year:  2003        PMID: 14661906     DOI: 10.1023/a:1026215221569

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  12 in total

Review 1.  Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration.

Authors:  U Schmidt-Erfurth; T Hasan
Journal:  Surv Ophthalmol       Date:  2000 Nov-Dec       Impact factor: 6.048

2.  Clinicopathologic studies of age-related macular degeneration with classic subfoveal choroidal neovascularization treated with photodynamic therapy.

Authors:  N G Ghazi; N M Jabbour; Z C De La Cruz; W R Green
Journal:  Retina       Date:  2001       Impact factor: 4.256

3.  Multifocal electroretinography in retinitis pigmentosa.

Authors:  M Seeliger; U Kretschmann; E Apfelstedt-Sylla; K Rüther; E Zrenner
Journal:  Am J Ophthalmol       Date:  1998-02       Impact factor: 5.258

4.  Imaging localized retinal dysfunction with the multifocal electroretinogram.

Authors:  M A Bearse; E E Sutter
Journal:  J Opt Soc Am A Opt Image Sci Vis       Date:  1996-03       Impact factor: 2.129

5.  Histological findings of surgically excised choroidal neovascular membranes after photodynamic therapy.

Authors:  U E Schnurrbusch; K Welt; L C Horn; P Wiedemann; S Wolf
Journal:  Br J Ophthalmol       Date:  2001-09       Impact factor: 4.638

6.  Localization of lipoprotein-delivered benzoporphyrin derivative in the rabbit eye.

Authors:  R Haimovici; M Kramer; J W Miller; T Hasan; T J Flotte; K T Schomacker; E S Gragoudas
Journal:  Curr Eye Res       Date:  1997-02       Impact factor: 2.424

7.  A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes.

Authors:  M Sickenberg; U Schmidt-Erfurth; J W Miller; C J Pournaras; L Zografos; B Piguet; G Donati; H Laqua; I Barbazetto; E S Gragoudas; A M Lane; R Birngruber; H van den Bergh; H A Strong; U Manjuris; T Gray; M Fsadni; N M Bressler
Journal:  Arch Ophthalmol       Date:  2000-03

8.  Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment.

Authors:  D Husain; M Kramer; A G Kenny; N Michaud; T J Flotte; E S Gragoudas; J W Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-09       Impact factor: 4.799

9.  Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.

Authors: 
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

10.  Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys.

Authors:  M Kramer; J W Miller; N Michaud; R S Moulton; T Hasan; T J Flotte; E S Gragoudas
Journal:  Ophthalmology       Date:  1996-03       Impact factor: 12.079

View more
  7 in total

Review 1.  The electroretinogram: a useful tool for evaluating age-related macular disease?

Authors:  Emma J Berrow; Hannah E Bartlett; Frank Eperjesi; Jonathan M Gibson
Journal:  Doc Ophthalmol       Date:  2010-03-16       Impact factor: 2.379

2.  Deficits in the electroretinogram in neovascular age-related macular degeneration and changes during photodynamic therapy.

Authors:  Alison M Mackay; Malcolm C Brown; Richard P Hagan; Anthony C Fisher; Ian Grierson; Simon P Harding
Journal:  Doc Ophthalmol       Date:  2007-08-02       Impact factor: 2.379

3.  Dynamics of retinal function after multiple photodynamic therapies in age-related macular degeneration: a report of cases.

Authors:  Beatrix Feigl; Brian Brown; Jan Lovie-Kitchin; Lawrence Lee
Journal:  Doc Ophthalmol       Date:  2006-03-06       Impact factor: 2.379

4.  Transitions of multifocal electroretinography following combined intravitreal bevacizumab and photodynamic therapy for polypoidal choroidal vasculopathy.

Authors:  Chengguo Zuo; Feng Wen; Jiaqing Li; Yan Liu; Meng Li
Journal:  Doc Ophthalmol       Date:  2009-01-31       Impact factor: 2.379

5.  Different transitions of multifocal electroretinogram recordings between patients with age-related macular degeneration and polypoidal choroidal vasculopathy after photodynamic therapy.

Authors:  H Imai; S Honda; Y Nakanishi; H Yamamoto; Y Tsukahara; A Negi
Journal:  Br J Ophthalmol       Date:  2006-07-06       Impact factor: 4.638

6.  The changes of pattern electroretinography at the early stage of photodynamic therapy.

Authors:  Ayse Oner; Sarper Karakucuk; Ertugrul Mirza; Kuddusi Erkilic
Journal:  Doc Ophthalmol       Date:  2006-03-02       Impact factor: 2.379

7.  Single-session photodynamic therapy combined with intravitreal ranibizumab for neovascular age-related macular degeneration: a comprehensive functional retinal assessment.

Authors:  Mariacristina Parravano; Vincenzo Parisi; Lucia Ziccardi; Adele Chiaravalloti; Massimiliano Tedeschi; Andrea Cacciamani; Barbara Boccassini; Antonluca Boninfante; Monica Varano
Journal:  Doc Ophthalmol       Date:  2013-08-13       Impact factor: 2.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.